由于BRISC缺乏,它通过调节β-catenin K63的在位化,导致心力衰竭
Lu Liu1, Guang-Ming Ren2, Chen Chen2
1Department of Nutrition and Food Hygiene, Capital Medical University, China. (L.L., W.-H.N., L.W.).
Hypertension (Dallas, Tex. : 1979)
|March 6, 2026
概括
这种BRISC复合物是一种K63特异的二维基因酶,通过调节β-catenin,防止高血压性心力衰竭. 准这种BRISC-β-catenin通路为心脏病提供了一个新的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 生物化学 生化学
背景情况:
- 高血压性心力衰竭的特点是不良的心脏重塑和功能障碍,潜在的分子机制尚未完全阐明.
- 与K63结合的二维基因被认为是影响心脏重塑的关键的翻译后调节机制.
- 研究人员研究了BRISC (BRCC3异酶复合体),这是一种针对K63连接的泛素链的双基因酶,研究其在高血压心脏重塑中的作用.
研究的目的:
- 研究BRISC综合体,特别是其支架子单元ABRO1和催化子单元BRCC3在高血压心脏改造的背景下所起的作用.
- 阐明BRISC在高血压条件下影响心脏功能和结构的分子机制.
- 在高血压心力衰竭的BRISC介导调节途径中确定潜在的治疗点.
主要方法:
- 对人类和小鼠高性心脏中的BRISC子单元表达的分析.
- 在基因改造小鼠 (全球/心肌细胞特异性 Abro1 淘汰/过度表达, Brcc3 淘汰) 中评估心脏表型,在基线和血管新生素 II 输入条件下.
- 利用了无处不在的形,共免疫沉,免疫沉质谱,CUT&Tag,无处不在的位突变和救援实验来识别BRISC基质和机制.
主要成果:
- 观察到BRISC支架子单位ABRO1的下调在心脏缩心脏的心肌细胞中.
- 在小鼠中,Abro1缺乏导致了自发性心脏缩和收缩功能障碍,由血管素II加剧.
- 阿布罗1的过度表达保护了血管新生素II诱导的心脏重塑,而Brcc3的淘汰效应模仿了阿布罗1缺陷表型,突出了BRISC的关键作用.
- 发现ABRO1与β-catenin直接相互作用,在K508分离K63结合的多基化,以抑制β-catenin的核积累和转录活性.
- 对β-catenin的药理抑制在Abro1缺乏的小鼠中挽救了心脏功能障碍.
结论:
- 布里斯克复合体作为一个关键的K63特异的二维基因酶,通过抑制β-catenin过度激活来维持心脏平衡.
- BRISC-β-catenin轴代表了管理高血压心力衰竭的有希望的新型治疗标.
- 了解BRISC在心脏重塑中的二氧化活性,可以为预防和治疗心力衰竭提供见解.
相关概念视频
01:17Pathophysiology of Heart Failure
4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
01:23Catenins
3.2K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.2K
02:54Canonical Wnt Signaling Pathway
10.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
01:41Non-Canonical Wnt Signaling Pathways
8.5K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
01:29Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K